Matthew Taylor
Stock Analyst at Jefferies
(4.44)
# 1,180
Out of 4,707 analysts
671
Total ratings
55.6%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintained: Buy | $210 | $179.10 | +17.25% | 31 | Sep 8, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $63 → $105 | $75.29 | +39.46% | 11 | Sep 8, 2026 | |
| MDT Medtronic | Reiterated: Hold | $95 | $92.39 | +2.82% | 41 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $135 | $105.52 | +27.94% | 44 | Aug 21, 2026 | |
| BSX Boston Scientific | Rated: Buy | $67 → $60 | $44.98 | +33.39% | 53 | Aug 21, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $90 → $92 | $66.78 | +37.78% | 13 | Jul 30, 2026 | |
| RMD ResMed | Maintained: Hold | $245 → $225 | $221.05 | +1.79% | 16 | Jul 10, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $455 | $276.43 | +64.60% | 35 | Jun 18, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $102 | $86.72 | +17.62% | 68 | May 27, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $100.44 | +9.52% | 13 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $142.28 | +181.14% | 30 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 | $84.53 | +32.50% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $24.86 | -23.57% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $75.04 | +53.25% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $19.88 | +141.45% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $12 | $18.49 | -35.10% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $19.99 | n/a | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 → $110 | $94.22 | n/a | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $80 | $80.70 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $18.62 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $1.28 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $350.16 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $137.00 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.00 → $34.50 | $16.60 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $14.81 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $9.33 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $16.26 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $46.59 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $5.43 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 364.00 → CHF 255.00 | CHF 231.20 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $319.26 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5.5 | $7.52 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $180.30 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €49.00 | €21.86 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $39.00 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.5 → $1 | $7.40 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $15.22 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
Becton, Dickinson and Company
Sep 8, 2026
Maintained: Buy
Price Target: $210
Current: $179.10
Upside: +17.25%
Establishment Labs Holdings
Sep 8, 2026
Reiterated: Buy
Price Target: $63 → $105
Current: $75.29
Upside: +39.46%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $95
Current: $92.39
Upside: +2.82%
Abbott Laboratories
Aug 21, 2026
Reiterated: Buy
Price Target: $135
Current: $105.52
Upside: +27.94%
Boston Scientific
Aug 21, 2026
Rated: Buy
Price Target: $67 → $60
Current: $44.98
Upside: +33.39%
GE HealthCare Technologies
Jul 30, 2026
Reiterated: Buy
Price Target: $90 → $92
Current: $66.78
Upside: +37.78%
ResMed
Jul 10, 2026
Maintained: Hold
Price Target: $245 → $225
Current: $221.05
Upside: +1.79%
Stryker
Jun 18, 2026
Maintained: Buy
Price Target: $465 → $455
Current: $276.43
Upside: +64.60%
Edwards Lifesciences
May 27, 2026
Maintained: Buy
Price Target: $102
Current: $86.72
Upside: +17.62%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $100.44
Upside: +9.52%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $142.28
Upside: +181.14%
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $84.53
Upside: +32.50%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $24.86
Upside: -23.57%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $75.04
Upside: +53.25%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $19.88
Upside: +141.45%
Oct 3, 2025
Maintained: Hold
Price Target: $15 → $12
Current: $18.49
Upside: -35.10%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $19.99
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $130 → $110
Current: $94.22
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $79 → $80
Current: $80.70
Upside: n/a
Aug 5, 2025
Maintained: Buy
Price Target: $28
Current: $18.62
Upside: n/a
Jun 4, 2025
Maintained: Buy
Price Target: $18
Current: $1.28
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: n/a
Current: $350.16
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $137.00
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: $33.00 → $34.50
Current: $16.60
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $14.81
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $9.33
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $16.26
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $105
Current: $46.59
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $5.43
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 231.20
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $319.26
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $7 → $5.5
Current: $7.52
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $180.30
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: €49.00
Current: €21.86
Upside: n/a
Dec 6, 2019
Maintained: Hold
Price Target: n/a
Current: $39.00
Upside: n/a
Mar 8, 2018
Maintained: Sell
Price Target: $1.5 → $1
Current: $7.40
Upside: n/a
Jul 19, 2017
Maintained: Hold
Price Target: $17 → $16
Current: $15.22
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a